# A Study of Bimatoprost 0.01% in the Clinical Setting

> **NCT01814761** · — · COMPLETED · sponsor: **Allergan** · enrollment: 312 (actual)

## Conditions studied

- Glaucoma, Primary Open Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost 0.01%

## Key facts

- **NCT ID:** NCT01814761
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2015-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01814761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01814761, "A Study of Bimatoprost 0.01% in the Clinical Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01814761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*